A Study of Selpercatinib (LY3527723) in Healthy Participants
Clinical trial NCT05338515 · COMPLETED
Trial details
- NCT number
- NCT05338515
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-12
- Primary completion
- 2019-03-12
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.